maravai lifesciences holdings glp-1 receptor agonist medications Market Size & Analysis, 2026-2033 The Landscape Of GLP-1 Receptor

ISBN 978-1-932564-68-6

doi:10.1038/s41429-025-00850-7 18

Neurological Relevance Preclinical evidence suggests broader neuroprotective potential: In traumatic brain injury models, SS-31 reduced mitochondrial swelling, neuronal loss, and neuroinflammation Aged mice treated with SS-31 showed significantly improved exercise tolerance, muscle strength, and mitochondrial efficiency Studies demonstrate protection against ischemic injury and enhanced cardiac output Phase 3 trials are ongoing for dry age-related macular degeneration and primary mitochondrial myopathy (Stealth BioTherapeutics pipeline) Implications for Brain Aging Mitochondrial dysfunction is a hallmark of brain aging and neurodegeneration

That's why we're putting our collective experience down on paper